- Apadaz https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/208653s000lbl.pdf#page=35 - Brilinta https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/022433s022lbl.pdf#page=25 - Simponi https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2017/125433s020s021lbl.pdf# page=32 - Depakene https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/018723s060,019680s047lbl. pdf#page=97 - Depakote ER https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/018723s060,019680s047lbl. pdf#page=97 - Steglujan https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/209805s001lbl.pdf#page=32
jueves, 15 de marzo de 2018
Drug Safety and Availability > Medication Guides
Drug Safety and Availability > Medication Guides
![U.S. Food and Drug Administration Header](https://blogger.googleusercontent.com/img/proxy/AVvXsEh74P7qmkHBRpE8WNBcdtmoF4O4P2HZ9uo-EHu3Z14pgHl0F-3baqeESxDF5edkC7CTsV3P64y2x8_VHLpk9mFz586mK5h-JBrTcc3WcW6mBYBuMkqvjF5bHehyphenhyphenmGcZ7tN1ZDDHX4xGRe9uFar0R_9NIQ7ZNZBSue6ew-JssvTJxaTx_A-An0poefzEGHsaQZ5KRvIdlNhYIfZyz1rkaPbhfJN-BYYYSwsEkTtxaMckaStezXt3upwHw7gFDHyabUCneQDND9i5iLzjIc1VSFxAZK2Hphpb1g=s0-d-e1-ft)
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario